Assessing nanoparticle risks to human health
The book will take a systematic look at nanoparticle risks within the paradigm of risk assessment, consider the limitations of this paradigm in dealing with the extreme uncertainties regarding many aspects of nanoparticle exposure and toxicity, and suggest new methods for assessing and managing risk...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Waltham, MA
William Andrew
2011
|
| Schriftenreihe: | Micro & nano technologies series
|
| Schlagworte: | |
| Online-Zugang: | lizenzpflichtig |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000cam a22000002 4500 | ||
|---|---|---|---|
| 001 | ZDB-30-ORH-048520047 | ||
| 003 | DE-627-1 | ||
| 005 | 20240228114820.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191206s2011 xx |||||o 00| ||eng c | ||
| 020 | |a 9781437778632 |c electronic bk. |9 978-1-4377-7863-2 | ||
| 020 | |a 1437778631 |c electronic bk. |9 1-4377-7863-1 | ||
| 035 | |a (DE-627-1)048520047 | ||
| 035 | |a (DE-599)KEP048520047 | ||
| 035 | |a (ORHE)9781437778632 | ||
| 035 | |a (DE-627-1)048520047 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 072 | 7 | |a MED |2 bisacsh | |
| 072 | 7 | |a MED |2 bisacsh | |
| 072 | 7 | |a MED |2 bisacsh | |
| 072 | 7 | |a MED |2 bisacsh | |
| 072 | 7 | |a TEC |2 bisacsh | |
| 082 | 0 | |a 610.28 |2 23 | |
| 245 | 1 | 0 | |a Assessing nanoparticle risks to human health |c Gurumurthy Ramachandran, editor |
| 264 | 1 | |a Waltham, MA |b William Andrew |c 2011 | |
| 300 | |a 1 online resource (xvii, 280 pages). | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Micro & nano technologies series | |
| 500 | |a Includes bibliographical references and index | ||
| 520 | |a The book will take a systematic look at nanoparticle risks within the paradigm of risk assessment, consider the limitations of this paradigm in dealing with the extreme uncertainties regarding many aspects of nanoparticle exposure and toxicity, and suggest new methods for assessing and managing risks in this context. It will consider the occupational environment where the potential for human exposure is the greatest as well as the issues relevant to occupational exposure assessment (e.g., the exposure metric) and the evidence from toxicological and epidemiological studies. A chapter will be devoted to how conventional risk assessment can be carried out for a candidate nanoparticle (e.g., carbon nanotubes), and the limitations that arise from this approach. We will propose several alternate methods in another chapter including screening assessments and adapting the rich methodological literature on the use of experts for risk assessment. Another chapter will deal with non-occupational populations, their susceptibilities, and life-cycle risk assessments. There will be a chapter on current risk management and regulatory oversight frameworks and their adequacy. This chapter will also include a discussion of US and EU approaches to risk assessment, as well as corporate approaches. | ||
| 650 | 0 | |a Nanoparticles |x Risk assessment | |
| 650 | 0 | |a Risk assessment | |
| 650 | 0 | |a Human beings | |
| 650 | 2 | |a Environmental Exposure |x adverse effects | |
| 650 | 2 | |a Nanoparticles |x adverse effects | |
| 650 | 2 | |a Risk Assessment | |
| 650 | 2 | |a Humans | |
| 650 | 4 | |a Nanoparticules ; Évaluation du risque | |
| 650 | 4 | |a Évaluation du risque | |
| 650 | 4 | |a Êtres humains | |
| 650 | 4 | |a risk assessment | |
| 650 | 4 | |a Homo sapiens (species) | |
| 650 | 4 | |a MEDICAL ; Allied Health Services ; Medical Technology | |
| 650 | 4 | |a MEDICAL ; Biotechnology | |
| 650 | 4 | |a MEDICAL ; Family & General Practice | |
| 650 | 4 | |a MEDICAL ; Lasers in Medicine | |
| 650 | 4 | |a TECHNOLOGY & ENGINEERING ; Biomedical | |
| 650 | 4 | |a Risk assessment | |
| 650 | 4 | |a Internet Resources | |
| 700 | 1 | |a Ramachandran, Gurumurthy |d 1963- |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |l TUM01 |p ZDB-30-ORH |q TUM_PDA_ORH |u https://learning.oreilly.com/library/view/-/9781437778632/?ar |m X:ORHE |x Aggregator |z lizenzpflichtig |3 Volltext |
| 912 | |a ZDB-30-ORH | ||
| 912 | |a ZDB-30-ORH | ||
| 951 | |a BO | ||
| 912 | |a ZDB-30-ORH | ||
| 049 | |a DE-91 | ||
Datensatz im Suchindex
| DE-BY-TUM_katkey | ZDB-30-ORH-048520047 |
|---|---|
| _version_ | 1818767286193881088 |
| adam_text | |
| any_adam_object | |
| author2 | Ramachandran, Gurumurthy 1963- |
| author2_role | ctb |
| author2_variant | g r gr |
| author_facet | Ramachandran, Gurumurthy 1963- |
| building | Verbundindex |
| bvnumber | localTUM |
| collection | ZDB-30-ORH |
| ctrlnum | (DE-627-1)048520047 (DE-599)KEP048520047 (ORHE)9781437778632 |
| dewey-full | 610.28 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.28 |
| dewey-search | 610.28 |
| dewey-sort | 3610.28 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03478cam a22006492 4500</leader><controlfield tag="001">ZDB-30-ORH-048520047</controlfield><controlfield tag="003">DE-627-1</controlfield><controlfield tag="005">20240228114820.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191206s2011 xx |||||o 00| ||eng c</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781437778632</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-4377-7863-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1437778631</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-4377-7863-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)048520047</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP048520047</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ORHE)9781437778632</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)048520047</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TEC</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610.28</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing nanoparticle risks to human health</subfield><subfield code="c">Gurumurthy Ramachandran, editor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Waltham, MA</subfield><subfield code="b">William Andrew</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xvii, 280 pages).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Micro & nano technologies series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The book will take a systematic look at nanoparticle risks within the paradigm of risk assessment, consider the limitations of this paradigm in dealing with the extreme uncertainties regarding many aspects of nanoparticle exposure and toxicity, and suggest new methods for assessing and managing risks in this context. It will consider the occupational environment where the potential for human exposure is the greatest as well as the issues relevant to occupational exposure assessment (e.g., the exposure metric) and the evidence from toxicological and epidemiological studies. A chapter will be devoted to how conventional risk assessment can be carried out for a candidate nanoparticle (e.g., carbon nanotubes), and the limitations that arise from this approach. We will propose several alternate methods in another chapter including screening assessments and adapting the rich methodological literature on the use of experts for risk assessment. Another chapter will deal with non-occupational populations, their susceptibilities, and life-cycle risk assessments. There will be a chapter on current risk management and regulatory oversight frameworks and their adequacy. This chapter will also include a discussion of US and EU approaches to risk assessment, as well as corporate approaches.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Nanoparticles</subfield><subfield code="x">Risk assessment</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Risk assessment</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Human beings</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Environmental Exposure</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Nanoparticles</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Risk Assessment</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Humans</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanoparticules ; Évaluation du risque</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Évaluation du risque</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Êtres humains</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">risk assessment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Homo sapiens (species)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MEDICAL ; Allied Health Services ; Medical Technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MEDICAL ; Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MEDICAL ; Family & General Practice</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MEDICAL ; Lasers in Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">TECHNOLOGY & ENGINEERING ; Biomedical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk assessment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internet Resources</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ramachandran, Gurumurthy</subfield><subfield code="d">1963-</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">TUM01</subfield><subfield code="p">ZDB-30-ORH</subfield><subfield code="q">TUM_PDA_ORH</subfield><subfield code="u">https://learning.oreilly.com/library/view/-/9781437778632/?ar</subfield><subfield code="m">X:ORHE</subfield><subfield code="x">Aggregator</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-ORH</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-ORH</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">BO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-ORH</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield></record></collection> |
| id | ZDB-30-ORH-048520047 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-18T08:47:28Z |
| institution | BVB |
| isbn | 9781437778632 1437778631 |
| language | English |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 online resource (xvii, 280 pages). |
| psigel | ZDB-30-ORH |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | William Andrew |
| record_format | marc |
| series2 | Micro & nano technologies series |
| spelling | Assessing nanoparticle risks to human health Gurumurthy Ramachandran, editor Waltham, MA William Andrew 2011 1 online resource (xvii, 280 pages). Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Micro & nano technologies series Includes bibliographical references and index The book will take a systematic look at nanoparticle risks within the paradigm of risk assessment, consider the limitations of this paradigm in dealing with the extreme uncertainties regarding many aspects of nanoparticle exposure and toxicity, and suggest new methods for assessing and managing risks in this context. It will consider the occupational environment where the potential for human exposure is the greatest as well as the issues relevant to occupational exposure assessment (e.g., the exposure metric) and the evidence from toxicological and epidemiological studies. A chapter will be devoted to how conventional risk assessment can be carried out for a candidate nanoparticle (e.g., carbon nanotubes), and the limitations that arise from this approach. We will propose several alternate methods in another chapter including screening assessments and adapting the rich methodological literature on the use of experts for risk assessment. Another chapter will deal with non-occupational populations, their susceptibilities, and life-cycle risk assessments. There will be a chapter on current risk management and regulatory oversight frameworks and their adequacy. This chapter will also include a discussion of US and EU approaches to risk assessment, as well as corporate approaches. Nanoparticles Risk assessment Risk assessment Human beings Environmental Exposure adverse effects Nanoparticles adverse effects Risk Assessment Humans Nanoparticules ; Évaluation du risque Évaluation du risque Êtres humains risk assessment Homo sapiens (species) MEDICAL ; Allied Health Services ; Medical Technology MEDICAL ; Biotechnology MEDICAL ; Family & General Practice MEDICAL ; Lasers in Medicine TECHNOLOGY & ENGINEERING ; Biomedical Internet Resources Ramachandran, Gurumurthy 1963- MitwirkendeR ctb TUM01 ZDB-30-ORH TUM_PDA_ORH https://learning.oreilly.com/library/view/-/9781437778632/?ar X:ORHE Aggregator lizenzpflichtig Volltext |
| spellingShingle | Assessing nanoparticle risks to human health Nanoparticles Risk assessment Risk assessment Human beings Environmental Exposure adverse effects Nanoparticles adverse effects Risk Assessment Humans Nanoparticules ; Évaluation du risque Évaluation du risque Êtres humains risk assessment Homo sapiens (species) MEDICAL ; Allied Health Services ; Medical Technology MEDICAL ; Biotechnology MEDICAL ; Family & General Practice MEDICAL ; Lasers in Medicine TECHNOLOGY & ENGINEERING ; Biomedical Internet Resources |
| title | Assessing nanoparticle risks to human health |
| title_auth | Assessing nanoparticle risks to human health |
| title_exact_search | Assessing nanoparticle risks to human health |
| title_full | Assessing nanoparticle risks to human health Gurumurthy Ramachandran, editor |
| title_fullStr | Assessing nanoparticle risks to human health Gurumurthy Ramachandran, editor |
| title_full_unstemmed | Assessing nanoparticle risks to human health Gurumurthy Ramachandran, editor |
| title_short | Assessing nanoparticle risks to human health |
| title_sort | assessing nanoparticle risks to human health |
| topic | Nanoparticles Risk assessment Risk assessment Human beings Environmental Exposure adverse effects Nanoparticles adverse effects Risk Assessment Humans Nanoparticules ; Évaluation du risque Évaluation du risque Êtres humains risk assessment Homo sapiens (species) MEDICAL ; Allied Health Services ; Medical Technology MEDICAL ; Biotechnology MEDICAL ; Family & General Practice MEDICAL ; Lasers in Medicine TECHNOLOGY & ENGINEERING ; Biomedical Internet Resources |
| topic_facet | Nanoparticles Risk assessment Risk assessment Human beings Environmental Exposure adverse effects Nanoparticles adverse effects Risk Assessment Humans Nanoparticules ; Évaluation du risque Évaluation du risque Êtres humains risk assessment Homo sapiens (species) MEDICAL ; Allied Health Services ; Medical Technology MEDICAL ; Biotechnology MEDICAL ; Family & General Practice MEDICAL ; Lasers in Medicine TECHNOLOGY & ENGINEERING ; Biomedical Internet Resources |
| url | https://learning.oreilly.com/library/view/-/9781437778632/?ar |
| work_keys_str_mv | AT ramachandrangurumurthy assessingnanoparticleriskstohumanhealth |